Last updated: 11/04/2018 11:54:30

Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Request patient level data
GSK study ID
SCO30003
See study documents
Clinicaltrials.gov ID
NCT00268216
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A multicentre, randomised, double-blind, parallel group, placebo-controlled study to investigate the long-term effects of salmeterol/fluticasone propionate (Seretide tm) 50/500mcg BD, salmeterol 50mcg BD and fluticasone propionate 500mcg BD, all delivered via the Diskus tm/Accuhaler tm inhaler, on mortality and morbidity of subjects with chronic obstructive pulmonary disease (COPD) over 3 years of treatment
Trial description: The purpose of this study is to see if fluticasone 500mcg/salmeterol 50mcg can improve the survival of subjects with COPD and also assess the long term safety profile of this drug.
Primary purpose:
Treatment
Trial design:
Parallel Assignment
Masking:
Not applicable
Allocation:
Randomized
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
  • Drug: Salmeterol 50mcg/ Fluticasone Propionate 500mcg
    • Enrollment:
    6228
    Primary completion date:
    Not applicable
    Observational study model:
    Not applicable
    Time perspective:
    Not applicable
    Clinical publications:
    Briggs A, Glick H, Lozano-Ortega G, et al. Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J 2009 Aug 28. [Epub ahead of print].
    Calverley PM, Anderson JA, Celli B, et al; TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007;356(8):775–89.
    Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008;178(4):332–8.
    Christine R Jenkins, Paul W Jones, Peter M A Calverley, Bartolome Celli, Julie A Anderson, Gary T Ferguson, Julie C Yates, Lisa R Willits, Jörgen Vestbo. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study . [Respir Res]. 2009;10(59):
    Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009;34(3):641–7.
    Ernst P, Suissa S. Pneumonia in elderly patients with chronic obstructive pulmonary disease. Curr Infect Dis Rep 2008;10(3):223–8.
    Ferguson GT, Calverley PM, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009;136(6):1456–65.
    Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B. Prevalence and progression of osteoporosis in patients with COPD: results from TORCH. Chest. 2009;136:1456-65
    Hanania NA. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Pulm Pharmacol Ther 2008;21(3):540–50.
    Houghton CM, Lawson N, Borrill ZL, et al. Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma. Respiratory Research 2007; 8: 52.
    Jenkins CR, Jones PW, Calverley PM, et al. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009;10:59. [Epub].
    Johnson M, Agusti AG, Barnes NC. Reflections on TORCH: potential mechanisms for the survival benefit of salmeterol/fluticasone propionate in COPD patients. COPD 2008;5:369–75.
    Keene ON, Vestbo J, Anderson JA, et al. Methods for therapeutic trials in COPD: lessons from the TORCH trial. Eur Respir J 2009;34(5):1018–23.
    M Bradley Drummond, Robert A Wise, Matthias John, Michael Zvarich, Lorcan P McGarvey. Accuracy of death certificates in chronic obstructive pulmonary disease: Analysis from the TORCH trial. [COPD]. 2010;7:179-185.
    Marchand E. Effect of pharmacotherapy on rate of decline of FEV(1) in the TORCH study. Am J Respir Crit Care Med 2009;179(5):426; author reply 426–7.
    McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD -- operations of the TORCH Clinical Endpoint Committee. Thorax 2007;62(5):411–5.
    Middleton PG. Management of patients with COPD: a comparison of the INSPIRE and TORCH studies. Am J Respir Crit Care Med 2008;178(1):106; author reply 106–7.
    Miravitlles M, Anzueto A. Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studies. Int J Chron Obstruct Pulmon Dis 2009;4:185–201
    Niewoehner DE. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"? COPD 2009;6(1):1–3.
    Peter M.A. Calverley, Julie A. Anderson, Bartolome Celli, Gary T. Ferguson, Christine Jenkins, Paul W. Jones, Courtney Crim, Lisa R. Willits, Julie C. Yates, Jørgen Vestbo. Cardiovascular events in patients with chronic obstructive pulmonary disease: TORCH study results. [Thorax]. 2010;65:719-725.
    Salmeterol plus fluticasone fails to reduce mortality in patients with COPD. Formulary 2007;42:245–6.
    Stockley RA. Progression of chronic obstructive pulmonary disease: impact of inflammation, comorbidities and therapeutic intervention. Curr Med Res Opin 2009;25:1235–45.
    Suissa S, Ernst P, Vandemheen KL, Aaron SD. Methodological issues in therapeutic trials of COPD. Eur Respir J 2008;31(5):927–33.
    Vestbo J and the TORCH Study Group. The TORCH (Towards a Revolution in COPD Health) survival study protocol. Eur Respir J 2004;24:206-210
    Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax 2009;64(11):939–43.
    A. Briggs, H. Glick, G. Lozano-Ortega, M. Spencer, P. Calverley, P. Jones, J. Vestbo, and On behalf of the TORCH investigators . Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J. 2010;35:532-9.
    Bartolome Celli, Jörgen Vestbo, Christine R. Jenkins, Paul W. Jones, Gary T. Ferguson, Peter M.A. Calverley, Julie C. Yates, Julie A. Anderson, Lisa R. Willits, Robert A. Wise; on behalf of the investigators of the TORCH study . Gender Differences in Mortality and Clinical Expressions of Patients with COPD: The TORCH Experience. Am J Respir Crit Care Med. 2010
    C. Crim, P. M. A. Calverley, J. A. Anderson, B. Celli, G. T. Ferguson, C. Jenkins, P. W. Jones, L. R. Willits, J. C. Yates, and J. Vestbo . Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J. 2009;34(3):641-647.
    Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators . Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. February 22nd 2007;356:775-789.
    Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins C, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM. Effect of Pharmacotherapy on Rate of Decline of Lung Function in COPD: Results from the TORCH Study. Am J Respir Crit Care Med. 2008;178:332-8.
    Christine R Jenkins, Bartolome Celli, Julie A Anderson, Gary T Ferguson, Paul W Jones, Jørgen Vestbo, Julie C Yates and Peter M A Calverley.Seasonality and determinants of COPD exacerbations: Results from the TORCH study .Eur Respir J.2012;39(1):38-45
    Christine R Jenkins, Bartolome Celli, Julie A Anderson, Gary T Ferguson, Paul W Jones, Jørgen Vestbo, Julie C Yates and Peter M A Calverley.Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study.Eur Respir J.2012;39(1):38-45
    Christine R Jenkins, Paul W Jones, Peter M A Calverley, Bartolome Celli, Julie A Anderson, Gary T Ferguson, Julie C Yates, Lisa R Willits, Jörgen Vestbo. Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study . Respir Res. 2009;10(59):
    Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B. Prevalence and progression of osteoporosis in patients with COPD: results from TORCH. Chest. 2009;136:1456-65.
    Ferguson GT, Calverley PMA, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B.Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.Chest.2009;136(6):1456-65
    Jørgen Vestbo, Julie A Anderson, Peter MA Calverley, Bartholome Celli, Gary T Ferguson, Christine Jenkins, Lisa R Willits, Julie C Yates, and Paul W Jones. Adherence to inhaled therapy, mortality, and hospital admission in COPD. Thorax. 2009;64:939-943.
    Kiri VA, Bettoncelli G, Testi R, Viegi G. Inhaled corticosteroids (ICS) are more effective in reducing the risk of rehospitalization or death in severe COPD patients when used with long-acting beta agonists (LABA) than with short-acting beta agonists (SABA). Respir Med. 2005;99:1115–1124
    Kiri VA, Pride NB, Soriano JB, Vestbo J.. Inhaled corticosteroids in COPD: results from two observational designs free of immortal-time bias. Am J Respir Crit Care Med. 2005;172:460–464.
    M Bradley Drummond, Robert A Wise, Matthias John, Michael Zvarich, Lorcan P McGarvey. Accuracy of death certificates in chronic obstructive pulmonary disease: Analysis from the TORCH trial. COPD. 2010;7:179-185.
    McGarvey L, John M, Anderson J, Zvarich M, Wise RA. Assessment of Cause-Specific Mortality in COPD -- Operations of the TORCH Clinical Endpoint Committee. Thorax. 2007 Feb 20
    Paul W. Jones, Peter M.A. Calverley, Julie A. Anderson, Bartolome Celli, Gary T. Ferguson, Christine Jenkins, Julie C. Yates, Jørgen Vestbo, Michael D. Spencer, on behalf of the TORCH investigators. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. . Respir Res. 2011;12(1):71
    Paul W. Jones, Peter M.A. Calverley, Julie A. Anderson, Bartolome Celli, Gary T. Ferguson, Christine Jenkins, Julie C. Yates, Jørgen Vestbo, Michael D. Spencer, on behalf of the TORCH investigators.Health status in chronic obstructive pulmonary disease across the world: measurements of treatment efficacy and determinants of change.Respir Res.2011;12:71
    Peter M.A. Calverley, Julie A. Anderson, Bartolome Celli, Gary T. Ferguson, Christine Jenkins, Paul W. Jones, Courtney Crim, Lisa R. Willits, Julie C. Yates, Jørgen Vestbo. Cardiovascular events in patients with chronic obstructive pulmonary disease: TORCH study results. Thorax. 2010;65:719-725.
    Sin DD, Wu L, Anderson JA, Anthonisen NR, Sonia Buist A, Sherwood Burge P, Calverley PM, Connett JE, Lindmark B, Pauwels RA, Postma DS, Soriano JS, Szafranski W, Vestbo J. Inhaled corticosteroids and mortality in COPD. Thorax. 2005;60:992-997.
    The TORCH Study Group. The TORCH (TOwards a Revolution in COPD Health) survival study protocol. Eur Respir J. 2004;24:206-210.
    Vestbo J, Calverley P, Celli B, Ferguson GT, Jenkins C, Jones PW.Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study.Clin Respir J.2011;5(1):44-9
    Medical condition
    Pulmonary Disease, Chronic Obstructive
    Product
    fluticasone propionate, fluticasone propionate/salmeterol, salmeterol
    Collaborators
    Not applicable
    Study date(s)
    September 2000 to November 2005
    Type
    Interventional
    Phase
    3

    Participation criteria

    Sex
    Female & Male
    Age
    40 - 80 years
    Accepts healthy volunteers
    No
    • Patients with COPD and FEV1 <60% of predicted normal and baseline (pre-bronchodilator) FEV1/FVC ratio <70%.
    • Current or ex-smokers with a smoking history of at least 10 pack-years.
    • Diagnosis of other respiratory disorders (including asthma).
    • Requirement for long term oxygen therapy.
    Inclusion and exclusion criteria
    Inclusion criteria:
    • Patients with COPD and FEV1 <60% of predicted normal and baseline (pre-bronchodilator) FEV1/FVC ratio <70%.
    • Current or ex-smokers with a smoking history of at least 10 pack-years.
    Exclusion criteria:
    • Diagnosis of other respiratory disorders (including asthma).
    • Requirement for long term oxygen therapy.

    Trial location(s)

    Location
    Status
    Contact us
    Contact us
    Location
    GSK Investigational Site
    DORDRECHT, Netherlands, 3317 NM
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Swansea, Massachusetts, United States, 02777
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Mexico, Mexico, 14000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Paris Cedex 04, France, 75181
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Riga, Latvia, LV 1038
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vista, California, United States, 92083
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Rio de Janeiro, Rio De Janeiro, Brazil, 20 551-030
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Oslo, Norway, N-1054
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Reykjavik, Iceland, 109
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Thessaloniki, Greece, 57010
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Fullerton, California, United States, 92835
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Patra, Greece, 26226
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Aarhus C, Denmark, DK-8000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Brandon, Florida, United States, 33511
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Morristown, Tennessee, United States, 37813
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Beijing, China, 100037
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Milan, Tennessee, United States, 38372
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Shanghai, China, 200025
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bodo, Norway, N-8092
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Moscow, Russia, 121 359
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pensacola, Florida, United States, 32514
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Bucharest, Romania, 050159
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sainte-Foy, Québec, Canada, G1V 4G5
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Toledo, Ohio, United States, 43617
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Montreal, Québec, Canada, H2X 2P4
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Diego, California, United States, 92103
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35235
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Buenos Aires, Buenos Aires, Argentina, 1272
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Charlotte, North Carolina, United States, 28207
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tainan, Taiwan, 704
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Longwood, Florida, United States, 32779
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Iasi, Romania, 700115
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Phoenix, Arizona, United States, 85008
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Brooklyn, New York, United States, 11217
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tau-Yuan County, Taiwan, 333
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Verdun, France, 55100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Singapore, Singapore, 119074
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tamarac, Florida, United States, 33321
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Francisco, California, United States, 94102
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Lebanon, New Hampshire, United States, 03756
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68124
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Johnson City, Tennessee, United States, 37601
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Namur, Belgium, 5000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Heraklion, Crete, Greece, 71409
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    HEERLEN, Netherlands, 6419 PC
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bialystok, Poland, 15-276
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Loveland, Colorado, United States, 80538
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bristol, Tennessee, United States, 37620
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Camperdown, New South Wales, Australia, 2050
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Katowice, Poland, 40-752
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Greenville, North Carolina, United States, 27834
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Warszawa, Poland, 01-138
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cartagena, Spain, 30203
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wichita, Kansas, United States, 67207
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    GÖTEBORG, Sweden, SE-413 45
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Schwetzingen, Baden-Wuerttemberg, Germany, 68723
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Alicante, Spain
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Zabrze, Poland, 41-800
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Russe, Bulgaria, 7000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bellingham, Washington, United States, 98226
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Diego, California, United States, 92117
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Miami, Florida, United States, 33136
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bangkok, Thailand, 10330
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Beijing, China, 100036
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Adelaide, South Australia, Australia, 5000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    South Bend, Indiana, United States, 46617
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Marietta, Georgia, United States, 30066
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bristol, Gloucestershire, United Kingdom, BS16 2EW
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    St. Charles, Missouri, United States, 63301
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    TROLLHÄTTAN, Sweden, SE-461 85
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Roanoke, Virginia, United States, 24016
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 13357
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kwun Tong, Hong Kong
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Madison, Wisconsin, United States, 53705
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Downington, Pennsylvania, United States, 19335
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Brescia, Lombardia, Italy, 25123
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Maurepas, France, 78310
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pleven, Bulgaria, 5800
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Brasov, Romania, 2200
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Marseille Cedex 20, France, 13915
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Albuquerque, New Mexico, United States, 87108
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Kiev, Ukraine, 03680
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Peoria, Illinois, United States, 61602
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tradate (VA), Lombardia, Italy, 21049
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lafayette, Louisiana, United States, 70503
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pueblo, Colorado, United States, 81001
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lappeenranta, Finland, 53130
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tatabanya, Hungary, 2800
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Melbourne, Victoria, Australia, 3050
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bergen, Norway, 5053
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cadillac, Michigan, United States, 49601
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    New York, New York, United States, 10029
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Wilmington, North Carolina, United States, 28401
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78217
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kuching, Malaysia, 93586
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Unknown, Spain
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Decatur, Georgia, United States, 30033
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lake Oswego, Oregon, United States, 97035
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cegléd, Hungary, 2700
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19140
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tonsberg, Norway, N-3117
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sofia, Bulgaria, 1202
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Windsor, Ontario, Canada, N8X 3V6
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tartu, Estonia, 51014
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35294-7340
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wellington, New Zealand, 6035
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Manila, Philippines
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Riga, Latvia, LV 1035
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sunset, Louisiana, United States, 70584
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cranston, Rhode Island, United States, 02920
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Chamalières, France, 63400
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Charleston, South Carolina, United States, 29406-7108
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Oklahoma City, Oklahoma, United States, 73104
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lai Chi kok, Hong Kong
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Porto Alegre, Rio Grande Do Sul, Brazil, 40110-160
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Fossvogur. Reykjavic, Iceland, 108
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    HELSINGBORG, Sweden, SE-251 87
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Palm Springs, Florida, United States, 33461
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Billings, Montana, United States, 59102
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Encinitas, California, United States, 92024
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Cleveland, Ohio, United States, 44024
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Beijing, China, 100039
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Zagreb, Croatia, 10000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    BODEN, Sweden, SE-961 64
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vantaa, Finland, 01400
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Taichung, Taiwan, 40705
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Avrille, France, 49240
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tanjong Bungah, Malaysia, 10450
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    North Chicago, Illinois, United States, 60064
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bardufoss, Norway, 9325
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Toronto, Ontario, Canada, M6H 3M2
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Medford, Oregon, United States, 97504
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Szolnok, Hungary, 5004
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vienna, Austria, A-1030
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    ROOSENDAAL, Netherlands, 4708 AE
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    New York, New York, United States, 10016
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Volda, Norway, 6100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Rio de Janeiro, Rio De Janeiro, Brazil, 21941-590
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Chania, Crete, Greece, 73300
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Scottsdale, Arizona, United States, 85251
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Diego, California, United States, 92123
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lille, France, 59800
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Ferolles Attilly, France, 77150
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Darmstadt, Hessen, Germany, 64287
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Geelong, Victoria, Australia, 3220
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    EKSJÖ, Sweden, SE-575 81
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Barakaldo (Vizcaya), Spain, 48903
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    BILTHOVEN, Netherlands, 3723
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Allentown, Pennsylvania, United States, 18104
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cape Town, South Africa, 8001
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    ChiangMai, Thailand, 50200
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    West Palm Beach, Florida, United States, 33409
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Annonay, France, 07100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    High Point, North Carolina, United States, 27262
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Blue Ridge, Georgia, United States, 30513
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    HELSINGBORG, Sweden, SE-252 26
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    São Paulo, São Paulo, Brazil, 05403-900
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Milano, Lombardia, Italy, 20152
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lohja, Finland, 08200
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    La Crosse, Wisconsin, United States, 54601
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19148
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    LIDKÖPING, Sweden, SE-531 85
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wroclaw, Poland, 50-449
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63110
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Boston, Massachusetts, United States, 02135
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bay Pines, Florida, United States, 33744
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Roswell, Georgia, United States, 30076
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Hannover, Niedersachsen, Germany, 30167
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Fort Collins, Colorado, United States, 80528
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    New Brunswick, New Jersey, United States, 8901
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Augusta, Georgia, United States, 30901
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Champaign, Illinois, United States, 61821
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Nedlands, Western Australia, Australia, 6009
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5M 2V8
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cebu City, Philippines, 6000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vicente López, Buenos Aires, Argentina, 1602
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Portland, Oregon, United States, 97213-2281
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Albany, New York, United States, 12208
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    New York, New York, United States, 10011
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Jaromer, Czech Republic, 551 01
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Corsicana, Texas, United States, 75110
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Hines, Illinois, United States, 60141-5099
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Singapore, Singapore, 238869
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Edmonton, Alberta, Canada, T6L 5X8
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vienna, Austria, A-1120
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Santiago De Compostela, Spain, 15706
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Rancho Mirage, California, United States, 92270
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Auckland, New Zealand, 1001
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Albany, New York, United States, 12205
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Toorak Gardens, South Australia, Australia, 5065
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    St. Joseph, Michigan, United States, 49085
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Nimes, France, 30000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    ZWOLLE, Netherlands, 8025 AB
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Mexico, D.F., Mexico, 06720
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Livonia, Michigan, United States, 48152
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Scarborough, Ontario, Canada, M1B 4Z8
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Longmont, Colorado, United States, 80501
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 10365
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vigo/Pontevedra, Spain, 36200
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Largo, Florida, United States, 33770
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Chesapeake, Virginia, United States, 23320
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kobenhavn NV, Denmark, 2400
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tauranga, New Zealand, 3001
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Ozark, Alabama, United States, 36360
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Ostrava - Fifejdy, Czech Republic, 728 80
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Hartford, Connecticut, United States, 06105
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Philadelphia, Pennsylvania, United States, 19129
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    TERNEUZEN, Netherlands, 4535 PA
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Santo Andre, São Paulo, Brazil, 09060-670
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sylmar, California, United States, 91342-1495
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sherbrooke, Québec, Canada, J1H 4J6
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Summit, New Jersey, United States, 07091
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Frankston, Victoria, Australia, 3199
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pretoria, South Africa, 0040
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99202
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Valencia, Spain, 46017
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Rio de Janeiro, Rio De Janeiro, Brazil, 20221-903
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Grenoble, France, 38000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Oostende, Belgium, 8400
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77030
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    BREDA, Netherlands, 4819 EV
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Traverse City, Michigan, United States, 49684
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lahore, Pakistan
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Barcelona, Spain, 08035
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Manchester, Lancashire, United Kingdom, M8 5RB
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Winston-Salem, North Carolina, United States, 27157
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Virginia Beach, Virginia, United States, 23454
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kowloon, Hong Kong
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Santiago, Región Metro De Santiago, Chile, 7500691
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lexington, Kentucky, United States, 40536
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Nanjing, Jiangsu, China, 210002
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Saint Quentin, France, 02100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Antonio, Texas, United States, 78205
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Hvidovre, Denmark, 2650
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Berkeley, California, United States, 94705
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Gilford, New Hampshire, United States, 3249
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Saint John, New Brunswick, Canada, E2M 3W5
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    N. Efkarpia, Thessaloniki, Greece, 564 29
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Chapel Hill, North Carolina, United States, 27514
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Helsinki, Finland, 00029
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Altamonte Springs, Florida, United States, 32701
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Kubang Kerian, Malaysia, 16150
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Phoenix, Arizona, United States, 85006
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Veurne, Belgium, 8630
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pace, Florida, United States, 32571
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Thunder Bay, Ontario, Canada, P7A 4V7
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Mowbray, South Africa, 7700
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bad Segeberg, Schleswig-Holstein, Germany, 23795
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cincinnati, Ohio, United States, 45219
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77074
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Loxahatchee, Florida, United States, 33470
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    New York, New York, United States, 10025
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Sesto San Giovanni (MI), Lombardia, Italy, 20099
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bielefeld, Nordrhein-Westfalen, Germany, 33602
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Long Beach, California, United States, 90822
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tabor, Czech Republic, 390 19
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Elda, Spain, 03600
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23225
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Corbeil Essonne, France, 91100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Charleston, South Carolina, United States, 29403
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68105
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    East Providence, Rhode Island, United States, 02914
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bethune Cedex, France, 62408
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Thessaloniki, Greece, 54642
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Minneapolis, Minnesota, United States, 55417
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Toulouse Cedex 9, France, 31059
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Mobile, Alabama, United States, 36608
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Portland, Oregon, United States, 97213
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Headington, Oxfordshire, United Kingdom, OX3 7LJ
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Calgary, Alberta, Canada, T2V 1P9
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Hradec Kralove, Czech Republic, 500 05
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Birmingham, Alabama, United States, 35294
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Ridley Park, Pennsylvania, United States, 19078
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Fredericksburg, Virginia, United States, 22401
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Stockton, California, United States, 95207
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Chongqing, China, 400037
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Mikkeli, Finland, 50100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Simpsonville, South Carolina, United States, 29681
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Denver, Colorado, United States, 80218
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Durban, KwaZulu- Natal, South Africa, 4126
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Larisa, Greece, 41110
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sepuldeva, California, United States, 91343
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68198-2456
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Franklin, Ohio, United States, 45005
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    La Plata, Buenos Aires, Argentina, 1900
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Lomme, France, 59160
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    London, United Kingdom, E1 1BB
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Shreveport, Louisiana, United States, 71103
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wichita, Kansas, United States, 67208
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Beijing, China, 100034
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Partizanske, Slovakia, 958 01
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kinkomaa, Finland, 40930
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Nantes, France, 44000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Banska Bystrica, Slovakia, 974 01
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Houston, Texas, United States, 77024
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Newcastle Upon Tyne, Northumberland, United Kingdom, NE1 4LP
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Jacksonville, Florida, United States, 32205
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Nove Zamky, Slovakia, 940 34
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tampa, Florida, United States, 33613
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Great Neck, New York, United States, 11023
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kaunas, Lithuania, LT-50009
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Atlanta, Georgia, United States, 30342
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Ferrara, Emilia-Romagna, Italy, 44100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pretoria, South Africa
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Salt Lake City, Utah, United States, 84102
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cincinnati, Ohio, United States, 45267-0405
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Quebec, Québec, Canada, G1S 4L8
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Saint John's, Newfoundland and Labrador, Canada, A1B 3V6
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Spartanburg, South Carolina, United States, 29303
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Mineola, New York, United States, 11501
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Kavala, Greece, 65403
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Coeur D'Alene, Idaho, United States, 83814
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cholet, France, 49300
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Fresno, California, United States, 93710
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Auburn, Maine, United States, 04210
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Luis Obispo, California, United States, 93401
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bois Guillaume, France, 76230
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Toledo, Ohio, United States, 43614-5809
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Fort Lauderdale, Florida, United States, 33316
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vienna, Austria, A-1210
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Guadalajara, Spain, 19002
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wels, Austria, A-4600
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Heidelberg, Victoria, Australia, 3084
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Diego, California, United States, 92120
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tarbes Cedex 09, France, 65013
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Melbourne, Victoria, Australia, 3004
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Alesund, Norway, 6026
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Jefferson City, Missouri, United States, 65109
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Omaha, Nebraska, United States, 68134
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Aberdeen, Hong Kong
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Rome, Georgia, United States, 30165
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pori, Finland, 28100
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tallinn, Estonia, 13419
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kuala Lumpur, Malaysia, 50586
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Exeter, Devon, United Kingdom, EX2 5DW
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Madrid, Spain, 28046
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Burbank, California, United States, 91505
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wangfujing, Beijing, China, 100730
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    HENGELO, Netherlands, 7555 DL
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Spokane, Washington, United States, 99204
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Singapore, Singapore, 308433
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Hoofddorp, Netherlands, 2130 AT
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kassel, Hessen, Germany, 34117
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kingsport, Tennessee, United States, 37660
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Skien, Norway, 3722
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Greer, South Carolina, United States, 29651
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Harstad, Norway, N-9480
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Oulainen, Finland, 86300
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Helsinki, Finland, 00290
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tai Po,, Hong Kong
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pittsburgh, Pennsylvania, United States, 15213
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Törökbálint, Hungary, 2045
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Moscow, Russia, 109240
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Chesterfield, Missouri, United States, 63017
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Singapore, Singapore, 169608
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Silkenborg, Denmark, DK-8600
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    East Orange, New Jersey, United States, 07018
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    North Gosford, New South Wales, Australia, 2250
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Athens, Greece, 15669
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Guadalajara, Jalisco, Mexico, 44340
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Arvada, Colorado, United States, 80002
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kaohsiung, Taiwan, 80708
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bronxville, New York, United States, 10708
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Atlantis, Florida, United States, 33462
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 10559
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Vizcaya, Spain, 48902
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Budapest, Hungary, 1529
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Trenton, New Jersey, United States, 8629
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Erie, Pennsylvania, United States, 16508
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Ponce, Puerto Rico, Puerto Rico, 731
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Calgary, Alberta, Canada, T2N 4N1
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bankstown, New South Wales, Australia, 22000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Orp-Jauche, Belgium, 1350
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Las Vegas, Nevada, United States, 89104
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Moscow, Russia, 105 077
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Liverpool, Lancashire, United Kingdom, L9 7AL
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cadiz, Spain, 11009
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Edina, Minnesota, United States, 55438
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90033
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    UTRECHT, Netherlands, 2584 CX
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Charleston, West Virginia, United States, 25304
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Praha 8, Czech Republic, 180 81
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Taipei, Taiwan, 112
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Caen Cedex, France, 14050
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Richmond, Virginia, United States, 23249
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Clearwater, Florida, United States, 33756
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Tours Cedex 1, France, 37000
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Jackson, Mississippi, United States, 39202
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kohtal-Jdrve, Estonia, 31 025
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sofia, Bulgaria, 1431
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Bruxelles, Belgium, 1180
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sherbrooke, Québec, Canada, J1H 1Z1
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Dunaujvaros, Hungary, 2400
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Elizabeth City, North Carolina, United States, 27909
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Kansas City, Missouri, United States, 64108
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Orihuela/Alicante, Spain, 03314
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Papagos/Athens, Greece, 15669
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Denver, Colorado, United States, 80206
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Nimes, France, 30900
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21204
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Chicago, Illinois, United States, 60612-3824
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    EDE, Netherlands, 6716 RP
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Praha 5, Czech Republic, 150 06
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Walnut Creek, California, United States, 94598
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Newark, New Jersey, United States, 07112
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    La Coruña, Spain, 15006
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Mississauga, Ontario, Canada, L5A 1N1
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Huntington, West Virginia, United States, 25701-1693
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Stamford, Connecticut, United States, 06902
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Varna, Bulgaria, 9010
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Doylestown, Pennsylvania, United States, 8901
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Heraklion, Crete, Greece, 71110
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Meaux, France, 77104
    Status
    Recruiting
    Contact us
    Location
    GSK Investigational Site
    Kralovsky Chlmec, Slovakia, 077 01
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Temuco, Región De La Araucania, Chile
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Jacksonville, Florida, United States, 32216
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Louisville, Kentucky, United States, 40215
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Bussolengo (VR), Veneto, Italy, 37012
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Quezon City, Philippines, 1101
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Oslo, Norway, N-0456
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Porto Alegre, Rio Grande Do Sul, Brazil, 90035 003
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Valparaiso, Valparaíso, Chile, 2341131
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    ARNHEM, Netherlands, 6815 AD
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Maple Ridge, British Columbia, Canada, V2X 2L5
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    St. Louis, Missouri, United States, 63141
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wheat Ridge, Colorado, United States, 80033
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Los Angeles, California, United States, 90048
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sunnyvale, California, United States, 94086
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Sandvika, Norway, 1337
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Baltimore, Maryland, United States, 21224
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Dubuque, Iowa, United States, 52001
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Hamilton, New Zealand, 2001
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Maroussi, Athens, Greece, 11526
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Trondheim, Norway, 7006
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Xian, Shaanxi, China, 710061
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Berlin, Berlin, Germany, 10178
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Sarasota, Florida, United States, 34239
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Cape Town, South Africa, 7505
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Winston-Salem, North Carolina, United States, 27103
    Status
    Terminated/Withdrawn
    Contact us
    Location
    GSK Investigational Site
    Madrid, Spain, 28040
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Wellington South, New Zealand, 6002
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Praha 8, Czech Republic, 182 00
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Jasper, Alabama, United States, 35501
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pittsburgh, Pennsylvania, United States, 15218
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Zephyrhills, Florida, United States, 33540
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Guangzhou, Guangdong, China, 510120
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Riverside, California, United States, 92506
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    San Diego, California, United States, 92103-6204
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Buffalo, New York, United States, 14221
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Pisa, Toscana, Italy, 56124
    Status
    Study Complete
    Contact us
    Location
    GSK Investigational Site
    Shenyang, Liaoning, China, 110015
    Status
    Study Complete
    Contact us

    Study documents

    Clinical study report
    Available language(s): English
    Download document(s)
    Scientific result summary
    Available language(s): English
    Download document(s)

    If you wish to request for full study report, please contact - [email protected]

    Results overview

    Refer to study documents

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    Not applicable

    Plain language summaries

    Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

    Additional information about the trial

    Participate in clinical trial
    Additional information
    Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.
    Click here
    Access to clinical trial data by researchers
    Visit website